# RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress

**Authors:** Tyler H. Stanage, Shudong Li, Sandra Segura-Bayona, Aurora I. Idilli, Rhona Millar, Graeme Hewitt, Simon J. Boulton

PMC · DOI: 10.1038/s41556-025-01852-1 · Nature Cell Biology · 2026-01-09

## TL;DR

The study shows how RPA exhaustion activates SLFN11, causing cell death in cancer cells under replication stress, especially when PrimPol is absent.

## Contribution

The paper reveals RPA exhaustion as a general mechanism for SLFN11 activation in replication stress, linking it to cisplatin sensitivity and PrimPol deficiency.

## Key findings

- SLFN11 activation occurs via RPA exhaustion and single-stranded DNA exposure in PrimPol-deficient cells.
- The USP1–WDR48 complex promotes SLFN11 activation and depends on the Fanconi anaemia pathway.
- Inhibiting DNA polymerase α rapidly activates SLFN11-dependent cell death.

## Abstract

SLFN11 is epigenetically silenced and confers chemoresistance in half of all cancers. In response to replication stress, SLFN11 triggers translation shutdown and p53-independent apoptosis, but how DNA damage activates SLFN11 remains unclear. Here through CRISPR-based screens we implicate SLFN11 as the critical determinant of cisplatin sensitivity in cells lacking primase–polymerase (PrimPol)-mediated repriming. SLFN11 and the downstream integrated stress response uniquely promote cisplatin-driven apoptosis in PrimPol-deficient cells. We demonstrate that replication protein A (RPA) exhaustion and single-stranded DNA exposure trigger SLFN11 activation and cell death when PrimPol is inactivated. We further identify the USP1–WDR48 deubiquitinase complex as a positive modulator of SLFN11 activation in PrimPol-deficient cells, revealing an addiction to the Fanconi anaemia pathway to resolve cisplatin lesions. Finally, we demonstrate that rapid RPA exhaustion on chemical inhibition of DNA polymerase α activates SLFN11-dependent cell death. Together, our results implicate RPA exhaustion as a general mechanism to activate SLFN11 in response to heightened replication stress.

Stanage et al. identify a role for transfer RNA nuclease SLFN11 in replication-stress-induced cell death in cisplatin-treated cells lacking PrimPol. SLFN11 is activated upon single-stranded DNA accumulation at stalled forks followed by replication protein A exhaustion and cell death.

## Linked entities

- **Genes:** SLFN11 (schlafen family member 11) [NCBI Gene 91607], PRIMPOL (primase and DNA directed polymerase) [NCBI Gene 201973], TP53 (tumor protein p53) [NCBI Gene 7157], USP1 (ubiquitin specific peptidase 1) [NCBI Gene 7398], WDR48 (WD repeat domain 48) [NCBI Gene 57599]
- **Proteins:** SLFN11 (schlafen family member 11), PRIMPOL (primase and DNA directed polymerase), RPA1 (replication protein A1)
- **Chemicals:** cisplatin (PubChem CID 5460033)

## Full-text entities

- **Genes:** PRIMPOL (primase and DNA directed polymerase) [NCBI Gene 201973] {aka CCDC111, MYP22, Primpol1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SLFN11 (schlafen family member 11) [NCBI Gene 91607] {aka SLFN8/9}, WDR48 (WD repeat domain 48) [NCBI Gene 57599] {aka Bun62, P80, SPG60, UAF1}, USP1 (ubiquitin specific peptidase 1) [NCBI Gene 7398] {aka UBP}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, POLA1 (DNA polymerase alpha 1, catalytic subunit) [NCBI Gene 5422] {aka NSX, PDR, POLA, VEODS, p180}
- **Diseases:** Fanconi anaemia (MESH:D000743), cancers (MESH:D009369)
- **Chemicals:** cisplatin (MESH:D002945)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12904793/full.md

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12904793/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12904793/full.md

---
Source: https://tomesphere.com/paper/PMC12904793